Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis (Q82223323)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 February 2012
edit
Language Label Description Also known as
English
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
scientific article published on 01 February 2012

    Statements

    Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit